CNS (Collaborating for Novel Solutions) Summit 2023

November 8, 2023
November 11, 2023
ENCORE BOSTON HARBOR, One Broadway, Everett, MA 02149

The CNS Summit is the curated event for visionary leaders in life sciences.

Attendees can expect a great speaker lineup. Kelly Dumais, Director eCOA Science and Consulting at Clario, will present a poster on the “Use and preferences for digital health technology accessibility and communication features” on 9 November between 5-7pm ET.

In addition, the agenda includes innovation showcases and spotlight sessions on topics such as artificial intelligence, decentralized trials, digital biomarkers, neuroscience and regulatory issues.

Join the CNS Summit 2023 and help drive the future of life sciences.

Session information:

Title: Use and preferences for digital health technology accessibility and communication features

Date: Thursday, November 9, 2023

Time: 5:00 pm – 7:00 pm


Providing various communication options and accessibility features via digital health technologies may provide greater inclusivity and usability for participants in clinical trials, but their familiarity and preferences for these features are poorly understood. This clinical research study investigated preference for communication and accessibility features that could enhance usability and engagement in clinical trials.

Participants show different preferences for how to communicate with friends/family versus healthcare professionals. Familiarity with various messaging methods was at least somewhat common. For reporting symptoms in a clinical trial while at home, participants were split between phone/video call and using smartphone touchscreens, and showed interest in having the device read questions and answers aloud and answering questions verbally.


Kelly Dumais headshot

Kelly Dumais, Ph.D.

Director, eCOA Science and Consulting at Clario

Dr. Dumais is a scientist with over 13 years of experience in behavioral and life science research. She has expertise in the implementation of electronic clinical outcome assessments (eCOA) and the development and validation of patient reported outcomes (PROs) to support labeling claims. She is currently the Director of eCOA Science and Consulting at Clario, a global data and technology company that helps to minimize risk in clinical trials. She consults on best practices for questionnaire design and eCOA design/use to drive data integrity and patient engagement and develops custom site rater training and participant training for improving accuracy in COA reporting and improving inter-and intra-rater reliability.